 |
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
|
|
|
|
|
|
|
Oxidoreductase
|
PDB id
|
|
|
|
1j8t
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
Contents |
 |
|
|
|
|
|
|
|
|
|
|
|
* Residue conservation analysis
|
|
|
|
 |
|
|
 |
 |
 |
 |
Enzyme class:
|
 |
E.C.1.14.16.1
- Phenylalanine 4-monooxygenase.
|
|
 |
 |
 |
 |
 |

Pathway:
|
 |
Phenylalanine and Tyrosine Biosynthesis
|
 |
 |
 |
 |
 |
Reaction:
|
 |
L-phenylalanine + tetrahydrobiopterin + O2 = L-tyrosine + 4a-hydroxytetrahydrobiopterin
|
 |
 |
 |
 |
 |
L-phenylalanine
|
+
|
tetrahydrobiopterin
|
+
|
O(2)
|
=
|
L-tyrosine
|
+
|
4a-hydroxytetrahydrobiopterin
|
|
 |
 |
 |
 |
 |
 |
 |
 |
Cofactor:
|
 |
Iron
|
 |
 |
 |
 |
 |
 |
 |
|
Molecule diagrams generated from .mol files obtained from the
KEGG ftp site
|
|
 |
 |
|
 |
|
 |
|
|
Gene Ontology (GO) functional annotation
|
|
|
|
 |
 |
 |
|
 |
 |
 |
 |
|
 |
|
Biological process
|
oxidation reduction
|
2 terms
|
 |
|
Biochemical function
|
monooxygenase activity
|
3 terms
|
 |
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
|
| |
|
DOI no:
|
J Mol Biol
314:279-291
(2001)
|
|
PubMed id:
|
|
|
|
|
| |
|
High resolution crystal structures of the catalytic domain of human phenylalanine hydroxylase in its catalytically active Fe(II) form and binary complex with tetrahydrobiopterin.
|
|
O.A.Andersen,
T.Flatmark,
E.Hough.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
The crystal structures of the catalytic domain (DeltaN1-102/DeltaC428-452) of
human phenylalanine hydroxylase (hPheOH) in its catalytically competent Fe(II)
form and binary complex with the reduced pterin cofactor
6(R)-L-erythro-5,6,7,8-tetrahydrobiopterin (BH4) have been determined to 1.7 and
1.5 A, respectively. When compared with the structures reported for various
catalytically inactive Fe(III) forms, several important differences have been
observed, notably at the active site. Thus, the non-liganded hPheOH-Fe(II)
structure revealed well defined electron density for only one of the three water
molecules reported to be coordinated to the iron in the high-spin Fe(III) form,
as well as poor electron density for parts of the coordinating side-chain of
Glu330. The reduced cofactor (BH4), which adopts the expected half-semi chair
conformation, is bound in the second coordination sphere of the catalytic iron
with a C4a-iron distance of 5.9 A. BH4 binds at the same site as
L-erythro-7,8-dihydrobiopterin (BH2) in the binary hPheOH-Fe(III)-BH2 complex
forming an aromatic pi-stacking interaction with Phe254 and a network of
hydrogen bonds. However, compared to that structure the pterin ring is displaced
about 0.5 A and rotated about 10 degrees, and the torsion angle between the
hydroxyl groups of the cofactor in the dihydroxypropyl side-chain has changed by
approximately 120 degrees enabling O2' to make a strong hydrogen bond (2.4 A)
with the side-chain oxygen of Ser251. Carbon atoms in the dihydroxypropyl
side-chain make several hydrophobic contacts with the protein. The iron is
six-coordinated in the binary complex, but the overall coordination geometry is
slightly different from that of the Fe(III) form. Most important was the finding
that the binding of BH4 causes the Glu330 ligand to change its coordination to
the iron when comparing with non-liganded hPheOH-Fe(III) and the binary
hPheOH-Fe(III)-BH2 complex.
|
|
|
|
|
| |
Selected figure(s)
|
|
|
| |
 |
 |
|
 |
|
 |
Figure 4.
Figure 4. Schematic diagram of BH[4]-protein interactions.
The BH[4] molecule is shown with purple bonds, nitrogen atoms
are blue, oxygen atoms red, water oxygens green, carbon atoms
black and the iron is yellow. The Figure was produced using
LIGPLOT21, and edited using CorelDRAW 9.0.
|
 |
Figure 5.
Figure 5. Top (a) and side (b) view of the electron density
of tetrahydrobiopterin contoured as 2F[o] -F[c] maps at 1.7 s
showing that all atoms are well defined. The non-planarity of
the pyrazine ring can clearly be identified in (b). The Figure
was produced using BOBSCRIPT20.
|
 |
|
|
|
| |
The above figures are
reprinted
by permission from Elsevier:
J Mol Biol
(2001,
314,
279-291)
copyright 2001.
|
|
| |
Figures were
selected
by an automated process.
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Literature references that cite this PDB file's key reference
|
|
 |
| |
PubMed id
|
 |
Reference
|
 |
|
|
|
 |
E.Olsson,
A.Martinez,
K.Teigen,
and
V.R.Jensen
(2011).
Formation of the iron-oxo hydroxylating species in the catalytic cycle of aromatic amino acid hydroxylases.
|
| |
Chemistry, 17,
3746-3758.
|
 |
|
|
|
|
 |
A.C.Muntau,
and
S.W.Gersting
(2010).
Phenylketonuria as a model for protein misfolding diseases and for the development of next generation orphan drugs for patients with inborn errors of metabolism.
|
| |
J Inherit Metab Dis, 33,
649-658.
|
 |
|
|
|
|
 |
S.W.Gersting,
F.B.Lagler,
A.Eichinger,
K.F.Kemter,
M.K.Danecka,
D.D.Messing,
M.Staudigl,
K.A.Domdey,
C.Zsifkovits,
R.Fingerhut,
H.Glossmann,
A.A.Roscher,
and
A.C.Muntau
(2010).
Pahenu1 is a mouse model for tetrahydrobiopterin-responsive phenylalanine hydroxylase deficiency and promotes analysis of the pharmacological chaperone mechanism in vivo.
|
| |
Hum Mol Genet, 19,
2039-2049.
|
 |
|
|
|
|
 |
A.Mijovilovich
(2008).
XANES study of the carboxylate binding mode in two pterin hydroxylases.
|
| |
Chem Biodivers, 5,
2131-2139.
|
 |
|
|
|
|
 |
J.Li,
and
P.F.Fitzpatrick
(2008).
Characterization of metal ligand mutants of phenylalanine hydroxylase: Insights into the plasticity of a 2-histidine-1-carboxylate triad.
|
| |
Arch Biochem Biophys, 475,
164-168.
|
 |
|
|
|
|
 |
P.C.Bruijnincx,
G.van Koten,
and
R.J.Klein Gebbink
(2008).
Mononuclear non-heme iron enzymes with the 2-His-1-carboxylate facial triad: recent developments in enzymology and modeling studies.
|
| |
Chem Soc Rev, 37,
2716-2744.
|
 |
|
|
|
|
 |
A.L.Pey,
F.Stricher,
L.Serrano,
and
A.Martinez
(2007).
Predicted effects of missense mutations on native-state stability account for phenotypic outcome in phenylketonuria, a paradigm of misfolding diseases.
|
| |
Am J Hum Genet, 81,
1006-1024.
|
 |
|
|
|
|
 |
C.D.Brown,
M.L.Neidig,
M.B.Neibergall,
J.D.Lipscomb,
and
E.I.Solomon
(2007).
VTVH-MCD and DFT studies of thiolate bonding to [FeNO]7/[FeO2]8 complexes of isopenicillin N synthase: substrate determination of oxidase versus oxygenase activity in nonheme Fe enzymes.
|
| |
J Am Chem Soc, 129,
7427-7438.
|
 |
|
|
|
|
 |
H.K.Leiros,
A.L.Pey,
M.Innselset,
E.Moe,
I.Leiros,
I.H.Steen,
and
A.Martinez
(2007).
Structure of phenylalanine hydroxylase from Colwellia psychrerythraea 34H, a monomeric cold active enzyme with local flexibility around the active site and high overall stability.
|
| |
J Biol Chem, 282,
21973-21986.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
G.R.Sura,
M.Lasagna,
V.Gawandi,
G.D.Reinhart,
and
P.F.Fitzpatrick
(2006).
Effects of ligands on the mobility of an active-site loop in tyrosine hydroxylase as monitored by fluorescence anisotropy.
|
| |
Biochemistry, 45,
9632-9638.
|
 |
|
|
|
|
 |
P.A.Frantom,
J.Seravalli,
S.W.Ragsdale,
and
P.F.Fitzpatrick
(2006).
Reduction and oxidation of the active site iron in tyrosine hydroxylase: kinetics and specificity.
|
| |
Biochemistry, 45,
2372-2379.
|
 |
|
|
|
|
 |
R.Pejchal,
E.Campbell,
B.D.Guenther,
B.W.Lennon,
R.G.Matthews,
and
M.L.Ludwig
(2006).
Structural perturbations in the Ala --> Val polymorphism of methylenetetrahydrofolate reductase: how binding of folates may protect against inactivation.
|
| |
Biochemistry, 45,
4808-4818.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
S.C.Daubner,
J.T.McGinnis,
M.Gardner,
S.L.Kroboth,
A.R.Morris,
and
P.F.Fitzpatrick
(2006).
A flexible loop in tyrosine hydroxylase controls coupling of amino acid hydroxylation to tetrahydropterin oxidation.
|
| |
J Mol Biol, 359,
299-307.
|
 |
|
|
|
|
 |
R.Tugyi,
G.Mezö,
E.Fellinger,
D.Andreu,
and
F.Hudecz
(2005).
The effect of cyclization on the enzymatic degradation of herpes simplex virus glycoprotein D derived epitope peptide.
|
| |
J Pept Sci, 11,
642-649.
|
 |
|
|
|
|
 |
A.J.Stokka,
R.N.Carvalho,
J.F.Barroso,
and
T.Flatmark
(2004).
Probing the role of crystallographically defined/predicted hinge-bending regions in the substrate-induced global conformational transition and catalytic activation of human phenylalanine hydroxylase by single-site mutagenesis.
|
| |
J Biol Chem, 279,
26571-26580.
|
 |
|
|
|
|
 |
H.Erlandsen,
A.L.Pey,
A.Gámez,
B.Pérez,
L.R.Desviat,
C.Aguado,
R.Koch,
S.Surendran,
S.Tyring,
R.Matalon,
C.R.Scriver,
M.Ugarte,
A.Martínez,
and
R.C.Stevens
(2004).
Correction of kinetic and stability defects by tetrahydrobiopterin in phenylketonuria patients with certain phenylalanine hydroxylase mutations.
|
| |
Proc Natl Acad Sci U S A, 101,
16903-16908.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
C.R.Scriver,
M.Hurtubise,
D.Konecki,
M.Phommarinh,
L.Prevost,
H.Erlandsen,
R.Stevens,
P.J.Waters,
S.Ryan,
D.McDonald,
and
C.Sarkissian
(2003).
PAHdb 2003: what a locus-specific knowledgebase can do.
|
| |
Hum Mutat, 21,
333-344.
|
 |
|
|
|
|
 |
P.A.Frantom,
and
P.F.Fitzpatrick
(2003).
Uncoupled forms of tyrosine hydroxylase unmask kinetic isotope effects on chemical steps.
|
| |
J Am Chem Soc, 125,
16190-16191.
|
 |
|
|
|
|
 |
P.F.Fitzpatrick
(2003).
Mechanism of aromatic amino acid hydroxylation.
|
| |
Biochemistry, 42,
14083-14091.
|
 |
|
|
|
|
 |
P.J.Waters
(2003).
How PAH gene mutations cause hyper-phenylalaninemia and why mechanism matters: insights from in vitro expression.
|
| |
Hum Mutat, 21,
357-369.
|
 |
|
|
|
|
 |
T.Solstad,
A.J.Stokka,
O.A.Andersen,
and
T.Flatmark
(2003).
Studies on the regulatory properties of the pterin cofactor and dopamine bound at the active site of human phenylalanine hydroxylase.
|
| |
Eur J Biochem, 270,
981-990.
|
 |
|
|
|
|
 |
E.C.Wasinger,
N.Mitić,
B.Hedman,
J.Caradonna,
E.I.Solomon,
and
K.O.Hodgson
(2002).
X-ray absorption spectroscopic investigation of the resting ferrous and cosubstrate-bound active sites of phenylalanine hydroxylase.
|
| |
Biochemistry, 41,
6211-6217.
|
 |
|
|
|
|
 |
M.J.Ryle,
and
R.P.Hausinger
(2002).
Non-heme iron oxygenases.
|
| |
Curr Opin Chem Biol, 6,
193-201.
|
 |
|
 |
 |
|
The most recent references are shown first.
Citation data come partly from CiteXplore and partly
from an automated harvesting procedure. Note that this is likely to be
only a partial list as not all journals are covered by
either method. However, we are continually building up the citation data
so more and more references will be included with time.
Where a reference describes a PDB structure, the PDB
codes are
shown on the right.
|
|